ABOUT 17th_ELSF
​> REGISTRATION
​> ATTENDEES​
​> PRESENTERS​
​> SPONSORS​​
​> SUPPORTERS​
​> NETWORKING​
> VENUE​
> ACCOMMODATION​

> ABOUT LAST YEAR​

contributing sponsor

Novo Holdings A/S

Novo Holdings is a holding and investment company that is responsible for managing the assets and the wealth of the Novo Nordisk Foundation. The purpose of Novo Holdings is to improve people’s health and the sustainability of society and the planet by generating attractive long-term returns on the assets of the Novo Nordisk Foundation.

Wholly owned by the Novo Nordisk Foundation, Novo Holdings is the controlling shareholder of Novo Nordisk A/S and Novozymes A/S and manages an investment portfolio with a long-term return perspective. In addition to managing a broad portfolio of equities, bonds, real estate, infrastructure and private equity assets, Novo Holdings is a world-leading life sciences investor. Through its Seeds, Venture, Growth, and Principal Investments teams, Novo Holdings invests in life science companies at all stages of development.
              
As of year-end 2022, Novo Holdings had total assets of EUR 108 billion.

www.novoholdings.dk